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Abstract
TNFa stimulates both pro- and anti-apoptotic signalling in hepatocytes. Anti-apoptotic signalling depends on a cascade of
ubiquitylation steps leading to NFkB activation. Using Sharpin-deficient mice, we show that the ubiquitin binding protein
Sharpin interacts with Hoip, an E3 ligase which generates linear ubiquitin chains. Sharpin-deficiency sensitized hepatocytes
to induction of apoptosis by TNFa even in the absence of transcriptional inhibition. TNFa induced activation of NFkB was
strongly reduced in hepatocytes from Sharpin-deficient mice, due to reduced and delayed phosphorylation and
degradation of IkBa. Injection of TNFa-inducing lipopolysaccharides led to strongly exacerbated liver damage and
premature death in Sharpin-deficient mice. Our findings point to an essential role of Sharpin in linear ubiquitin chain
formation, NFkB activation, and protection of the liver against inflammatory damaging signals.
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Introduction
Signalling through the NFkB pathway controls cellular events
including inflammation, proliferation and apoptosis. In hepato-
cytes, activation of NFkB is induced by TNFa and constitutes an
anti-apoptotic signal, which counterbalances the pro-apoptotic
branch of TNFa dependent signalling initiated by activation of
caspase-8 [1–3]. NFkB activation relies on a cascade of ubiquityla-
tion events which trigger activation or degradation of signalling
intermediates. The type of linkage determines the specificity for
ubiquitin chain dependent signalling [4]. Besides internal lysine
residues K48 and K63, which have been widely studied, linear (N-
to C-terminal) ubiquitin chains are essential for activation of NFkB
[5]. Formation of linear chains is catalyzed by a linear ubiquitin
chain assembly complex (LUBAC) made up of E3 ligases Hoip and
HOIL-1L [6]. Both proteins contain several ubiquitin binding zinc
finger motifs of the Npl4 type (NZF). Interaction between HOIL-1L
and Hoip is mediated by a ubiquitin like (Ubl) domain in HOIL-1L
and a ubiquitin associated (UBA) motif in Hoip. During incubation
of cells with TNFa, LUBAC is recruited to the TNF receptor
complex [7] and ubiquitylates the NFkB essential modulator,
NEMO [8].
Interestingly, HOIL-1L has a close homolog named Sharpin
which shares two functional domains with HOIL-1L, the Ubl
domain and the NZF-type zinc finger. Sharpin is not an E3 ligase
as it lacks the really interesting new gene motifs (RING fingers) present
in HOIL-1L and Hoip. Sharpin was initially discovered as an
interaction partner of postsynaptic Shank proteins [9]. However,
expression of Sharpin is not limited to neuronal tissues, indicating
that Sharpin fulfills non-synaptic functions. Seymour et al. [10]
described a loss-of-function mutation in the mouse Sharpin gene
which causes a phenotype termed chronic proliferative dermatitis
mutation (cpdm). Mice suffer from eosinophilic dermatitis,
multiple organ inflammation, absence of Peyer’s patches, spleno-
megaly and abnormal lymphoid architecture [11]. Initial studies in
the skin of Sharpin-deficient mice pointed to alterations in NFkB
signalling consistent with a constitutive activation of NFkB [12].
More recently, however, it became clear that Sharpin is a
component of the LUBAC complex and contributes to TNFa-
induced activation of NFkB [13–15]. Here we show that Sharpin
is involved in canonical NFkB activation in hepatocytes pointing
to a critical role of Sharpin for liver cell survival. TNFa induced
activation of NFkB was found strongly reduced in hepatocytes
from Sharpin-deficient mice, due to diminished and delayed
phosphorylation and degradation of IkBa. This led to increased
apoptosis upon TNFa treatment. Since the liver is continuously
exposed to food antigens and bacterial toxins from the gut via the
portal vein, inflammatory mediators such as TNFa are constantly
produced in this organ. Being one component of the LUBAC
complex, Sharpin seems to be part of the hepatocellular defence,
favouring anti-apoptotic signalling and thereby counteracting liver
damage under physiological conditions.
Results
The domain structures of Hoip, HOIL-1L and Sharpin are
shown in Figure 1A. The similarity of Sharpin to HOIL-1L
indicates that Sharpin might also bind to ubiquitin chains via the
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29993NZF domain and to Hoip, an ubiquitin E3 ligase of the LUBAC
complex. An interaction with ubiquitin was demonstrated by
preparing a GST fusion protein of the NZF domain and
incubation with different types of ubiquitin chains. Here we
observed that the Sharpin NZF domain specifically associated with
K48 and K63 linked chains as well as linear chains (Fig. 1B).
To test for an interaction with Hoip, GFP-tagged Sharpin and
Flag-tagged Hoip were expressed in HEK293 cells. When Sharpin
Figure 1. Sharpin interacts with ubiquitin and the E3 ubiquitin ligase Hoip. A. Domain structure of HOIL-1L, Hoip and Sharpin. Sharpin is
similar to HOIL-1L in its Ubl and NZF domains but lacks the Ring/IBR/Ring E3 ligase motif. For Hoip and Sharpin, positions used to generate deletion
constructs are indicated. B. The NZF domain of Sharpin binds ubiquitin. An immobilized GST fusion protein of the NZF domain (or GST alone) was
incubated with linear, K48 or K63 linked polyubiquitin chains; after centrifugation and washing, input and precipitate samples were analyzed by
Western blotting with anti-ubiquitin. C. The Ubl domain of Sharpin binds to Hoip. GFP-fusion proteins of Sharpin or fragments thereof were
coexpressed with Flag-tagged Hoip in HEK293 cells. Cell lysates were subjected to immunoprecipitation of GFP containing proteins using GFP-Trap
matrix, and input (left) and precipitate (right) samples were analyzed by Western blotting using anti-GFP (upper panels) and anti-Flag (lower panels)
antibodies. Note that the isolated Ubl domain (residues 171–310) of Sharpin precipitates Hoip very efficiently despite low expression levels. D. The
central region of Hoip mediates interaction with Sharpin. Flag-tagged fragments of Hoip were coexpressed with GFP-Sharpin, and subjected to
immunoprecipitation of GFP, as in C. E. The UBA domain of Hoip is sufficient for interaction with Sharpin. Myc-tagged Sharpin was coexpressed with a
GFP-Hoip encompassing the UBA domain, or GFP alone. Cell lysates were subjected to immunoprecipitation of GFP and input (in) and precipitate (p)
samples were analyzed by Western blotting. F. Interaction in hepatocarcinoma cells. Constructs encoding GFP as a fusion with full length Sharpin
(amino acids 1–382), or only the N-terminal region (residues 1–171) were expressed in Huh-7 hepatocarcinoma cells. After cell lysis, GFP-containing
proteins were immunoprecipitated using GFP-Trap matrix. Input (in) and precipitate (p) samples were analyzed by Western blotting using antibodies
against human Hoip (upper panel) or GFP (lower panel).
doi:10.1371/journal.pone.0029993.g001
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could be efficiently coprecipitated (Fig. 1C). By using deletion
constructs we could identify the Ubl domain of Sharpin as the
motif responsible for this interaction. On the other hand, a series
of deletion constructs for Hoip was tested for interaction with full-
length Sharpin (Fig. 1D). Here a fragment containing residues 1–
686 showed efficient interaction, whereas residues 1–396 did not
interact. Interestingly, residues 1–602 showed a rather weak
interaction. As this fragment contains most but not all amino acids
of the UBA domain, we assumed that the UBA domain mediates
the interaction on behalf of Hoip. This was confirmed by
coexpressing myc-tagged Sharpin with a GFP fusion protein of
the UBA domain of Hoip only (residues 537–686). Precipitation of
this GFP fusion, but not of GFP alone, led to efficient
coprecipitation of Sharpin (Fig. 1E). Furthermore, overexpression
and immunoprecipitation of GFP-Sharpin leads to efficient
coprecipitation of endogenous Hoip expressed in the human
Huh-7 hepatocarcinoma cell line (Fig. 1F).
Both HOIL-1L and Hoip are widely expressed. Similarly, as
shown here by Western blotting, Sharpin was found to be
expressed in all tissues analyzed, with low levels in heart and
skeletal muscle tissue. Tissues from Sharpin-deficient mice were
used as negative control for antibody staining (Fig. 2). Previous
experiments have shown that deficiency of HOIL-1L interferes
with NFkB activation and leads to enhanced apoptosis in
hepatocytes after TNFa incubation [8], and that Sharpin
contributes to TNFa signalling in various cell types [13–15].
Therefore we asked whether the absence of Sharpin also
contributes to TNFa induced apoptosis in the liver. Apoptosis of
hepatocytes can be induced by TNFa in combination with
Actinomycin D (ActD). Thus, the anti-apoptotic branch of TNFa
signalling is blocked by inhibiting transcription, whereas the pro-
apoptotic caspase-8/caspase-3 cascade remains unaffected. Hepa-
tocytes from wild type (wt) and Sharpin-deficient mice were
incubated with TNFa alone, or with ActD/TNFa. Analysis of
caspase-3 activation indicated that apoptosis was induced in
hepatocytes from Sharpin-deficient mice by the ActD/TNFa
combination and, to a weaker extent, in hepatocytes from wt mice.
Strikingly, treatment with TNFa alone induced cleavage of
caspase-3 in cells from Sharpin-deficient, but not wt mice
(Fig. 3A). Even after prolonged times of incubation, little
caspase-3 activation was observed in wt hepatocytes incubated
with TNFa alone, while the appearance of the active form of
caspase-3 was readily observed in Sharpin-deficient cells after 24–
72 hours (Fig. 3B). Quantification of caspase-3 enzyme activity
confirmed these data (Fig. 3C). By monitoring the activity of
caspase-8 (which is upstream of caspase-3) we observed that the
smaller, active fragments of caspase-8 appeared in hepatocytes
from Sharpin-deficient, but not wt cells (Fig. 3D). Furthermore, we
showed that incubation with TNFa alone induced fragmentation
of genomic DNA in Sharpin-deficient, but not wt hepatocytes.
Cells from both genotypes showed DNA-fragmentation when
incubated with the ActD/TNFa combination, as expected
(Fig. 3E). In addition, we performed FACS analysis of TNFa
treated hepatocytes with the membrane impermeable dye
propidium iodide (PI; Fig. 3F,G). Here we observed that the
number of PI-positive hepatocytes increased only marginally in
TNFa incubated wt cells (8.3% in non-incubated to 11.4% in
incubated cells), whereas the frequency of PI-positive Sharpin-
deficient hepatocytes nearly doubled upon TNFa incubation
(15.3% to 27%). As expected, incubation of wt and Sharpin-
deficient hepatocytes with ActD/TNFa as a control showed an
increase of PI-positive cells in both samples (Fig. 3G).
Our data indicated that caspase-dependent pro-apoptotic
signalling is activated by ActD/TNFa in wt and Sharpin-deficient
hepatocytes, whereas the anti-apoptotic, transcription dependent
pathway is partially lost in Sharpin-deficient cells. Therefore we
analyzed whether NFkB activation is altered in cells lacking
Sharpin. A reporter vector encoding the firefly (Photinus) luciferase
coding sequence under control of NFkB promoter elements was
cotransfected into primary hepatocytes in combination with a
CMV promoter driven Renilla luciferase plasmid. Cells were again
incubated with TNFa and analyzed for both luciferase activities.
Here we observed that activation of the NFkB dependent
promoter was significantly stronger in wt cells (2.3-fold) than in
Sharpin-deficient hepatocytes (1.5-fold; Fig. 4A). This was
mirrored in the transcriptional response of the NFkB responsive
gene coding for A20, a negative regulator of NFkB signalling.
Analysis by quantitative real time RT-PCR showed that TNFa
incubation increased the cellular levels of A20 mRNA more than
5.3-fold in wt cells, but only 3-fold in Sharpin-deficient cells
(Fig. 4B). For a more detailed analysis we focused on the
phosphorylation and subsequent degradation of IkBa. In wt cells,
we observed rapid phosphorylation of IkBa within 10 minutes of
incubation with TNFa (Fig. 4C,D). Levels of phospho-IkBa then
declined concomitantly with a decrease of overall IkBa levels
(Fig. 4E,F). In Sharpin-deficient cells, TNFa induced phosphor-
ylation was detectable but the signal intensity at the 10 minute
time point was significantly decreased. Maximum phosphorylation
levels were observed not until 20 minutes of incubation with
TNFa, where they matched those obtained in wt cells.
Phosphorylation is the key signal leading to degradation of IkBa;
in agreement, we observed that degradation of IkBa was delayed
and incomplete in Sharpin-deficient cells (Fig. 4E,F). Importantly,
delayed degradation was associated with a failure of the active
transcription factor p65/RelA to translocate to the nucleus in
Sharpin-deficient cells upon TNFa incubation (Figure 4G).
Figure 2. Sharpin is ubiquitously expressed in mouse tissues. The tissues indicated were prepared from wt and Sharpin-deficient mice; after
lysis in RIPA buffer and centrifugation, clear supernatants were analyzed by Western blotting using anti-Sharpin (upper panels) or anti-GAPDH (lower
panels). WT mice (
+/+); Sharpin-deficient mice (
2/2).
doi:10.1371/journal.pone.0029993.g002
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mediated inflammatory responses in the liver in vivo. Injection of
lipopolysaccharide (LPS) is known to induce TNFa release from
Kupffer cells, which causes hepatocyte cell death in presence of
transcriptional inhibition [16]. Importantly, injection of a single
dose of LPS alone led to acute liver damage (as determined by
serum alanine aminotransferase levels [ALT]) and in several cases
death in Sharpin-deficient mice, whereas control mice exhibited
Figure 3. TNFa induces apoptosis in hepatocytes from Sharpin-deficient mice. A. Activation of caspase-3. Hepatocytes were isolated from
wt and Sharpin-deficient mice. After 24 hours in culture, cells were incubated with TNFa alone for 24 hours (T) or in combination with ActD (A/T) for
18 hours. Cell lysates were analyzed by Western blotting with an antibody against caspase-3 (top) or GAPDH (bottom). Caspase-3 blots were
subjected to long exposure to monitor appearance of the small, active fragments of caspase-3. B. Time course of caspase-3 cleavage. Hepatocytes
isolated as described in A were incubated with TNFa for the times indicated. Cell lysates were analyzed by Western blotting with caspase-3 and
GAPDH antibodies. C. Caspase-3 enzyme activity. Hepatocytes from two wt and two Sharpin-deficient mice were incubated with TNFa, and caspase-3
activity was monitored in quadruplicate for each animal using a caspase-3 assay kit. ANOVA/Tukey test; ***, p,0.0001, ns.-not significant. D. Time
course of caspase-8 cleavage. Hepatocytes from wt and Sharpin-deficient mice were incubated as described in B and cell lysates were analyzed by
Western blotting with an antibody recognizing the cleaved intermediate (p43) and active (p18) forms of caspase-8. E. DNA-fragmentation.
Hepatocytes were incubated with TNFa for the times indicated or in combination with ActD (A/T) for 18 hours; genomic DNA was analyzed, and
DNA-fragmentation was analyzed by agarose gel electrophoresis. F, G. Quantification of PI-positive cells. FACS analysis of hepatocytes from wt and
Sharpin-deficient cells after incubation with TNFa for 24 hours or ActD/TNFa for 20 hours. In F, Histogram of propidium iodide (PI) intensity
indicating PI-positive wt (dotted line; 11.4%) and Sharpin-deficient (solid line; 27%) hepatocytes after 24 hours of TNFa incubation. G. Relative
proportion of PI-positive cells after incubation with TNFa or ActD/TNFa. Equal numbers of cells are depicted for all experiments. One typical of two
experiments is shown. WT mice (
+/+); Sharpin-deficient mice (
2/2).
doi:10.1371/journal.pone.0029993.g003
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29993Figure 4. Reduced NFkB activation by TNFa in primary hepatocytes from Sharpin-deficient mice. A. NFkB activity assay. Hepatocytes
isolated from wt and Sharpin-deficient mice were transfected with reporter vectors encoding CMV-driven Renilla luciferase and NFkB promoter
dependent Photinus luciferase. After incubation with TNFa for 24 hours, cell lysates were analyzed for activity of both luciferases; NFkB promoter
activity is depicted as the ratio between Photinus and Renilla luciferase activities from three independent experiments. ANOVA/Tukey test **,
*** p,0.01/0.001, respectively; n=3. B. Real time RT-PCR analysis. Hepatocytes isolated from wt and Sharpin-deficient mice were incubated with
TNFa for 24 hours. After isolation of RNA, levels of the mRNA coding for A20 were determined by quantitative real time RT-PCR relative to levels of
mRNA coding for ATP synthase beta. C,D. Phosphorylation of IkBa. Hepatocytes were incubated with TNFa for the times indicated. Cell lysates were
analyzed by Western blotting using the antibodies indicated (C). In D, the amount of phospho-IkBa from three independent experiments as shown in
C is quantified. The intensity of phospho-IkBa signals was normalized on GAPDH signals; in a second step, data were normalized on the maximum
value (in each case the 10 minute time point in wt cells). *, +/+ data significantly different from 2/2 data; p,0.05; n=3; t-test. E,F. Degradation of
IkBa. Hepatocytes were incubated as described in C, and analyzed by Western blotting with the antibodies indicated. In F, the amount of the amount
of IkBa from three independent experiments as shown in E is quantified. In this case the amount of IkBa in the control experiment (no TNFa
incubation) was set as 100% for each genotype. G. Nuclear translocation of NFkB. Hepatocytes were incubated with TNFa as indicated; cytosolic and
nuclear fractions were prepared and analyzed by Western blotting with antibodies against GAPDH (cytosolic marker), Lamin B (nuclear marker) and
p65/RelA. Note that the intensity of the signal for the p65/RelA component of NFkB increases in nuclei of TNFa-incubated wt, but not Sharpin-
deficient cells. WT mice (
+/+); Sharpin-deficient mice (
2/2).
doi:10.1371/journal.pone.0029993.g004
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and Sharpin-deficient mice exhibited a strong increase in serum
TNFa levels, which was, however, less pronounced in Sharpin-
deficient mice (Fig. 5C). This may be due to the fact that the gene
coding for TNFa is itself a target gene of NFkB. As observed before
[17], our histological analysis showed severe inflammatory reaction
withpredominant lymphocytic infiltration in sections obtained from
Sharpin-deficient mice, whereas normal liver structure and no
inflammatory infiltrates were found in wt mice. After LPS injection,
liver tissue from wt mice exhibited small inflammatory infiltrates. In
Sharpin-deficient animals, we detected again a severe inflammatory
reaction with lymphocyte infiltration. In addition we observed
necrotic and apoptotic cell death of hepatocytes (Fig. 5D–H).
Furthermore, analysis of liver tissue lysates showed the activation of
the caspase-8/caspase-3 cascade. We detected the cleaved and
active forms of both caspase-8 and caspase-3 in LPS treated
Sharpin-deficient mice, whereas LPS treated wt mice remained
unaffected (Fig. 5I). These results are in agreement with the massive
increase in serum ALT levels in Sharpin-deficient mice.
Discussion
Our data extend previous evidence showing that Sharpin, by
virtue of its interaction with the ubiquitin E3 ligase Hoip, is a
Figure 5. LPS induces severe liver failure in Sharpin-deficient mice. Wt and Sharpin-deficient mice (age: 9 weeks) were injected with LPS
(4 mg/kg i.p.; 7 animals per genotype; 4 animals per genotype in saline injected control group). A. Survival curve. Three out of seven Sharpin-deficient
mice died within the first 8 hours after injection. B. Serum ALT activity. Surviving animals were sacrificed after 8 hours and analyzed for serum alanine
aminotransferase (ALT) levels. C. TNFa release. Serum TNFa levels were determined 1 hour after LPS treatment from all mice (including those which
died within the first 8 hours) by ELISA. D–H. Pathological examination after 8 hours of treatment. Liver sections were H&E stained. Note the presence
of lymphocytic infiltrates in liver from Sharpin-deficient mice (E,G) as well as necrosis after LPS injection (G,H). I. Activation of the caspase cascade.
Liver tissue lysates of saline (S) and LPS (L) treated mice were analyzed by Western blotting using Caspase-3 and Caspase-8 specific antibodies, as
described in Figure 3. Note the appearance of cleaved caspases in LPS treated Sharpin-deficient mice only (unspecific band marked with an asterisk).
doi:10.1371/journal.pone.0029993.g005
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LUBAC [13–15]. Sharpin is highly similar to HOIL-1L, another
E3 ligase, which together with Hoip is responsible for the
attachment of linear ubiquitin chains to target proteins [5,6].
The similarity between HOIL-1L and Sharpin is limited to the
Ubl and NZF domains. In both proteins the Ubl domains mediate
interaction with Hoip; in contrast to results by Ikeda et al. [14]
who suggested that Hoip uses its NZF domain to interact with
Sharpin, we find here that the UBA domain of Hoip is responsible
for the interaction, in agreement with [15]. The UBA domain of
Hoip is also required for interaction with HOIL-1L [8], pointing
to a common mode of interaction. Apparently the NZF domains of
Sharpin and HOIL-1L fulfill similar functions as both bind to
ubiquitin chains (Fig. 1B; see also [13–15]). In addition, Sharpin
contains an N-terminal region of unknown function.
Recent work has shown that the E3 activity of Hoip (but not of
HOIL-1L) is responsible for activity of the complex. A truncated
HOIL-1L protein lacking the E3 ligase domain could functionally
replace full-length HOIL-1L [6,8]. Sharpin does not carry an E3
ligase domain, and it is likely that Sharpin is a structural, but not a
catalytic component of the LUBAC complex. We show here that in
hepatocytes Sharpin is required for efficient signal transduction from
TNFa to NFkB. In Sharpin-deficient hepatocytes, incubation with
TNFa alone results in increased apoptosis, as shown by DNA-
fragmentation and PI-staining. Recently, similar results were obtained
in primary keratinocytes (13). We further show that increased
apoptosis is due to activation of the caspase-8/caspase-3 cascade. In
wt hepatocytes TNFa induces a survival signal via NFkB-dependent
expression of anti-apoptotic proteins which is inhibited by incubation
with the transcriptional inhibitor ActD [18,19]. We observed an even
increased level of TNFa-induced caspase-3 activation in Sharpin-
deficient vs. wt hepatocytes in presence of ActD, suggesting that ActD
only incompletely inhibited hepatocellular transcription still giving rise
to Sharpin-dependent survival signals.
The increase in apoptosis in hepatocytes lacking Sharpin is due
to a failure in fast and complete activation of the canonical NFkB
pathway upon TNFa incubation. Phosphorylation and degrada-
tion of IkBa are reduced and delayed in Sharpin-deficient
hepatocytes, and consequently NFkB is unable to translocate to
the nucleus and activate transcription after TNFa incubation.
Thus the anti-apoptotic branch of the TNFa signal is attenuated,
tipping the balance towards apoptosis.
Our data are in contrast to work by Liang et al. [12], who
observed constitutive activity of NFkB in the skin of Sharpin-
deficient mice. At present it is not easy to reconcilethese differences.
However, Gijbels et al. analyzed several organs of Sharpin-deficient
mice and found that cellular infiltration of eosinophils is not limited
to the skin but also affects several other organs [17]. Therefore,
NFkB activation in the skin may be secondary to the strong
inflammatory reaction in Sharpin-deficient mice.
It should be noted that NFkB activation is not lost completely.
Both Sharpin and HOIL-1L contribute to full LUBAC activity
and may be important for substrate recognition or subcellular
targeting of the complex. Similar to Sharpin-deficient mice,
HOIL-1L knockout mice are viable but exhibit TNFa-induced
apoptosis in hepatocytes [8]. Walczak and coworkers [7,13]
reported that LUBAC is recruited to the TNF-receptor upon
activation; the delay in IkBa phosphorylation in Sharpin-deficient
cells might be due to insufficient recruitment of LUBAC to the
TNF-receptor complex and point to a role for Sharpin in the
targeting of LUBAC to the TNF-receptor.
NFkB signalling is one of the most important survival pathways
of hepatocytes; mice lacking the p65/RelA component of NFkB
die in utero due to hepatocyte apoptosis and liver degeneration [20].
NFkB activation is also required to protect the adult liver from
acute and chronic injury, since hepatocyte specific NEMO
knockout mice showed increased sensitivity to TNFa-induced
liver damage, developed a phenotype of spontaneous chronic
hepatitis associated with increased hepatocyte apoptosis, liver
inflammation, steatosis, compensatory hepatocyte proliferation
and finally development of hepatocellular carcinoma [21]. The
relevance of this pathway for protection of hepatocytes against
inflammation is illustrated by our in vivo experiments, where we
observe massive liver damage, necrosis and death in Sharpin-
deficient mice upon LPS injection. Therefore it seems that this
pathway is safeguarded in hepatocytes by different, more or less
redundant, activation steps in the canonical activation pathway
leading to IkBa degradation and translocation of NFkB. Finally,
compared to the widely used liver injury models depending on
transcriptional inhibition, Sharpin-deficient mice might repre-
sent a model to study mechanisms and consequences of failure
in this pathway being more related to injury-dependent liver
pathology.
Materials and Methods
Ethics Statement
All animal experiments were performed according to local
regulations of the state authorities in Hamburg, Germany. In
particular, permission was obtained from ‘‘Amt fu ¨r Gesundheits-
und Verbraucherschutz’’ of ‘‘Beho ¨rde fu ¨r Soziales, Familie,
Gesundheit und Verbraucherschutz’’, State Government of Freie
und Hansestadt Hamburg, for perfusion of the liver and removal
of hepatocytes from anaesthetized mice (registration number G
21301/591-00.33, obtained on September 1, 2009). Permission for
injections of LPS into wt and Sharpin-deficient mice was obtained
with the registration number 105/10, Beho ¨rde fu ¨r Soziales,
Familie, Gesundheit und Verbraucherschutz, Hamburg,
20.01.2011 and 31.03.2011.
Mice
Sharpin-deficient (cpdm) mice were obtained from The Jackson
Laboratories and maintained as heterozygous mice on C57/Bl6
background. For genotyping, the genomic region encompassing
the one base pair deletion in exon 1 of the Sharpin gene which leads
to the cpdm phenotype was amplified from genomic DNA by PCR
using primers CGGACCGTGCCTGGAG and CACGAATGT-
GAAAGGAAAAG, and sequenced using GATCAGAAATGT-
CGCCGC.
Antibodies and reagents
Anti-Sharpin was generated by custom immunization of rabbits
using a GST-fusion protein of the N-terminal domain (residues 1–
171) of rat Sharpin by Biogenes GmbH (Berlin, Germany).
Antibodies against IkBa, P-IkBa, Caspase-3 (8G10), Cleaved
Caspase-8 (Asp387) and GAPDH were obtained from Cell
Signaling Technologies (New England Biolabs, Frankfurt am
Main, Germany); anti-GFP from Chromotek (Munich, Germany);
anti-Flag from Sigma-Aldrich (Munich, Germany); anti-ubiquitin
from Chemicon (Millipore, Schwalbach, Germany); anti-Hoip
from Abcam (Cambridge, USA) and anti-laminB from Progen
Biotechnik (Heidelberg, Germany). Recombinant mouse TNFa
was from SINO Biological Inc. (Beijing, China), Actinomycin D
(ActD) from Th. Geyer (Hamburg, Germany). Caspase-3 activity
was measured using a Colorimetric Assay Kit (Sigma-Aldrich);
luciferase activity was determined using the Dual-LuciferaseH
Reporter Assay System (Promega, Mannheim, Germany).
Role of Sharpin in TNFa Signalling
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For expressing a GST fusion of the NZF domain of rat Sharpin,
a cDNA fragment coding for residues 310–382 was cloned into
pGEX4T2; protein was expressed in E.coli strain BL21, purified
using glutathione sepharose (GE Healthcare, Munich, Germany)
and left on the beads. For pulldown assays with ubiquitin chains
(Boston Biochem, Boston, MA), GST-NZF or GST alone was
incubated with ubiquitin chains in 150 mM NaCl; 10 mM ZnCl2;
20 mM Tris, pH 6.8; 5 mM b-mercaptoethanol; 0.1% Triton-X
100 for 2 hours at 4uC. After washing, samples were analyzed by
Western blotting.
Expression in human cell lines, immunoprecipitation
A cDNA coding for rat Sharpin was obtained from Dr.
Eunjoon Kim (Daejon, South Korea). cDNA fragments were
amplified by PCR with primers carrying appropriate restriction
sites and cloned into pEGFP-C vectors in frame with the EGFP
coding sequence. A cDNA coding for Hoip was obtained from
Origene (Rockville, USA); the coding region was cloned into
pCMV2B, leading to expression of N-terminally Flag-tagged
Hoip. For the generation of deletion constructs we took
advantage of existing restriction sites in the Hoip cDNA
sequence. For expression, HEK293 cells were cotransfected with
pEGFP-Sharpin and pCMV-Hoip plasmids using Turbofect
(Fermentas GmbH, St. Leon-Rot, Germany). Cells were lysed
in RIPA buffer and lysates were cleared by centrifugation
(204006 g; 4uC; 20 min). GFP-containing fusion proteins were
precipitated with GFP-trap matrix (Chromotek). After washing,
samples were analyzed by Western blotting. Huh-7 cells were
transfected with GFP-Sharpin using Turbofect, followed by lysis
and immunoprecipitation as described for HEK293 cells.
Preparation of primary hepatocytes
Hepatocytes were isolated from 6 to 9 weeks old mice by a
modification of the 2-step collagenase perfusion method of Seglen
[22,23] followed by 10 min centrifugation in a 90% Percoll
gradient (GE Healthcare) at 506 g to obtain highly purified
hepatocytes. For culture of hepatocytes, William’s E+Gluta-
MAX
TM-I medium (Gibco, Karlsruhe, Germany) was supple-
mented with 10% FBS (Gibco), 1% penicillin/streptomycin
(Biochrom AG seromed, Berlin, Germany) and 1% L-glutamine
(Invitrogen-GIBCO, Karlsruhe, Germany). Hepatocytes were
transfected using Lipofectamin 2000 (Invitrogen, Darmstadt,
Germany) according to the manufacturer’s protocol. For activa-
tion of NFkB and/or induction of apoptosis hepatocytes were
incubated either with 40 ng/ml TNFa alone or with ActD
(100 nM) and TNFa (40 ng/ml) as described previously [22]. For
Western Blot analysis, cells were lysed in 50 mM Tris/HCl
(pH 8.0); 150 mM NaCl; 1% NP40; 0.5% Na-Deoxycholat;
5 mM EDTA; 0.1% SDS; 16 Phosphatase Inhibitor Cocktail
(Roche Applied Sience, Mannheim, Germany) and 16 Protease
Inhibitor Cocktail (Sigma-Aldrich). For Western Blot analysis of
mouse liver tissue, protein lysates were prepared as described
previously [19]. For DNA-fragmentation analysis, cells were lysed
in 10 mM Tris/HCL pH 8; 1 mM EDTA and 0.2% Triton X-
100. After centrifugationthelowmolecular weight DNA-containing
supernatant was digested with RNase A for 1 hour at 37uC (final
concentration 60 mg/ml). Subsequently, SDS (final concentration
0.5%) and Proteinase K (final concentration 150 mg/ml) were
added and incubated for 1 hour at 50uC. After that DNA was
precipitated with isopropanol, dissolved in 10 mM Tris/HCL
pH 8; 1 mM EDTA and analyzed on a 2% agarose gel.
For separation of cytosolic and nuclear fractions, cells were
lysed in 10 mM HEPES pH 7.8; 10 mM KCl; 0.1 mM EDTA
and 16 Protease Inhibitor Cocktail (Sigma-Aldrich) for 20 min.
NP-40 (final concentration 0.5%) was added and cells
were incubated for 5 min. After centrifugation (50006 g) the
supernatant, containing the cytosolic fraction, was harvested. The
nuclei-containing pellet was resuspended in 20 mM HEPES
pH 7.8; 500 mM KCl; 1 mM EDTA; 10% Glycerol; 1 mM
DTT and 16 Protease Inhibitor Cocktail (Sigma-Aldrich) and
lysed for 30 min. After centrifugation (120006 g) the superna-
tant, containing the nuclear proteins, was harvested. Both
fractions were analyzed by Western blotting.
Flow cytometric analysis
Primary hepatocytes derived from 7 weeks old male mice
were cultured and stimulated as described above and harvested
by trypsinisation. A total of 5610
5 hepatocytes were stained
using standard Annexin V (Alexa FluorH 647) and Propidium
Iodid (PI) staining protocol (Biolegend, Fell, Germany). Data
were recorded using the BD FACSCanto II system and BD
FACSDiva software (BD Biosciences, Heidelberg, Germany)
a n da n a l y z e dw i t hF C Se x p r e s s4( D e N o v oS o f t w a r e ,L o s
Angeles, USA).
Detection of mRNA by Real Time RT-PCR
Total RNA was extracted from hepatocytes using TRIzol reagent
(Invitrogen) and reverse transcribed using the Verso cDNA synthesis
Kit (Abgene, Epsom, UK) according to the manufacturer’s protocol.
Oligonucleotides for PCR reactions were obtained from Metabion
International AG (Martinsried, Germany) with the following
sequences (59R39): A20 forward: CCAGGTTCCAGAA-
CAATGTC, A20 reverse: CTCCATACAGAGTTCCTCAC, ATP-
synthase beta forward: ATTGCCATCTTGGGTATGGA, ATP-
synthase beta reverse: AATGGGTCCCACCATGTAGA. Real time
RT-PCR was performed using the C1000 Thermal Cycler+CFX 96
Real-Time System (Bio-Rad, Munich, Germany) and the Max-
imaTM SYBR Green qPCR Master Mix (Fermentas GmbH).
Reactions were carried out in a 10 mlv o l u m e .
Application of LPS in vivo
Lipopolysaccharide (LPS) from Salmonella abortus equi was
purchased from Sigma-Aldrich and administered i.p. at a
concentration of 4 mg/kg. Hepatocyte damage was assessed
8 hours after LPS administration by measuring plasma enzyme
activities of alanine aminotransferase (ALT) using an automated
procedure (COBAS MIRAH; Roche, Switzerland; [24]). Plasma
TNFa levels were measured by sandwich ELISA as described
previously [25].
Histology
Liver tissue from mice was fixed in 4% phosphate-buffered
formalin and embedded into paraffin. 3 mm paraffin sections were
H&E stained and basic histomorphology of the specimens was
evaluated.
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